Insider · CIK 0001143789

APPLE TREE PARTNERS II LP

Reports to the SEC for 2 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001143789

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-07-06	RNTXRein Therapeutics, Inc.J Other	10% Owner	JOther	−1.38M sh	—	—	0
2018-06-26	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−10.5K sh	$5.45	−$57.4K	1,380,241
2018-06-25	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−913 sh	$5.86	−$5,353.01	1,390,769
2018-06-22	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−94.8K sh	$5.98	−$567K	1,391,682
2018-06-21	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−1,447 sh	$5.30	−$7,669.1	1,486,498
2018-06-20	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−5,200 sh	$5.30	−$27.6K	1,487,945
2018-06-19	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−139 sh	$5.30	−$736.7	1,493,145
2018-06-18	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−1,432 sh	$5.35	−$7,661.2	1,493,284
2018-06-15	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−7,961 sh	$5.32	−$42.3K	1,494,716
2018-06-12	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−10.8K sh	$5.40	−$58.6K	1,502,677
2018-06-11	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−18.5K sh	$5.41	−$100K	1,513,520
2018-06-08	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−9,617 sh	$5.40	−$52K	1,532,045
2018-06-07	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−20 sh	$5.47	−$109.5	1,541,662
2018-04-19	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−105K sh	$6.29	−$660K	1,541,682
2018-04-17	RNTXRein Therapeutics, Inc.S Sale	10% Owner	SSale	−3,105 sh	$7.05	−$21.9K	1,646,481
2017-07-05	RNTXRein Therapeutics, Inc.C Conversion	10% Owner	CConversion	+18.8K sh	—	—	19,022
2017-07-05	RNTXRein Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.78M sh	—	—	1,799,586
2017-07-05	RNTXRein Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−1.25M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series A-1 Preferred StockC Conversion	10% Owner	CConversion	−615K sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−3.71M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series C-1 Preferred StockC Conversion	10% Owner	CConversion	−2.97M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series C-2 Preferred StockC Conversion	10% Owner	CConversion	−4.24M sh	—	—	0
2017-07-05	RNTXRein Therapeutics, Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−6.78M sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+4.22M sh	—	—	4,218,641
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.5M sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−798K sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series B-2 Preferred StockC Conversion	Director, 10% Owner	CConversion	−645K sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−14.6M sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series D-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−8.71M sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series D-2 Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.54M sh	—	—	0
2014-09-22	ELDNEledon Pharmaceuticals, Inc. · Series D-3 Preferred StockC Conversion	Director, 10% Owner	CConversion	−13.4M sh	—	—	0

Recent filings

Accepted (ET)
Jul 104
APPLE TREE PARTNERS II LP0001012975-18-000906
SEC(opens sec.gov)
Jun 264
APPLE TREE PARTNERS II LP0001012975-18-000866
SEC(opens sec.gov)
Jun 214
APPLE TREE PARTNERS II LP0001012975-18-000862
SEC(opens sec.gov)
Jun 194
APPLE TREE PARTNERS II LP0001012975-18-000855
SEC(opens sec.gov)
Jun 144
APPLE TREE PARTNERS II LP0001012975-18-000846
SEC(opens sec.gov)
Jun 114
APPLE TREE PARTNERS II LP0001012975-18-000512
SEC(opens sec.gov)
Apr 194
APPLE TREE PARTNERS II LP0001012975-18-000358
SEC(opens sec.gov)
Jul 74
AILERON THERAPEUTICS INC0000899243-17-018102
SEC(opens sec.gov)

Companies

Address

47 HULFISH STREET SUITE 441

PRINCETON, NJ, 08542